1. Home
  2. SPFI vs SRDX Comparison

SPFI vs SRDX Comparison

Compare SPFI & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPFI
  • SRDX
  • Stock Information
  • Founded
  • SPFI 1941
  • SRDX 1979
  • Country
  • SPFI United States
  • SRDX United States
  • Employees
  • SPFI N/A
  • SRDX N/A
  • Industry
  • SPFI Major Banks
  • SRDX Medical/Dental Instruments
  • Sector
  • SPFI Finance
  • SRDX Health Care
  • Exchange
  • SPFI Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • SPFI 509.9M
  • SRDX 416.1M
  • IPO Year
  • SPFI 2019
  • SRDX 1998
  • Fundamental
  • Price
  • SPFI $35.20
  • SRDX $29.00
  • Analyst Decision
  • SPFI Buy
  • SRDX Buy
  • Analyst Count
  • SPFI 3
  • SRDX 2
  • Target Price
  • SPFI $39.67
  • SRDX $43.00
  • AVG Volume (30 Days)
  • SPFI 31.3K
  • SRDX 69.7K
  • Earning Date
  • SPFI 07-17-2025
  • SRDX 07-30-2025
  • Dividend Yield
  • SPFI 1.71%
  • SRDX N/A
  • EPS Growth
  • SPFI N/A
  • SRDX N/A
  • EPS
  • SPFI 3.00
  • SRDX N/A
  • Revenue
  • SPFI $193,655,000.00
  • SRDX $121,575,000.00
  • Revenue This Year
  • SPFI $11.59
  • SRDX N/A
  • Revenue Next Year
  • SPFI $5.75
  • SRDX $3.70
  • P/E Ratio
  • SPFI $11.74
  • SRDX N/A
  • Revenue Growth
  • SPFI N/A
  • SRDX N/A
  • 52 Week Low
  • SPFI $25.43
  • SRDX $26.00
  • 52 Week High
  • SPFI $40.91
  • SRDX $42.44
  • Technical
  • Relative Strength Index (RSI)
  • SPFI 47.99
  • SRDX 48.86
  • Support Level
  • SPFI $33.66
  • SRDX $28.67
  • Resistance Level
  • SPFI $35.60
  • SRDX $29.87
  • Average True Range (ATR)
  • SPFI 0.85
  • SRDX 0.75
  • MACD
  • SPFI -0.19
  • SRDX -0.05
  • Stochastic Oscillator
  • SPFI 46.11
  • SRDX 26.60

About SPFI South Plains Financial Inc.

South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: